Sign In
Buy INCY
$97.98
+5.74 (+6.22%)
At Close: Jun 03, 2026
Will Positive Regulatory Updates Further Boost INCY Stock?
10:31am, Monday, 20'th Oct 2025
Incyte's strong 2025 performance is fueled by Jakafi's sustained growth and label expansion of Opzelura.
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #ESMO25--Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced CRC and KRAS G12D Inhibitor in Advanced PDAC.
US Bancorp DE Has $1.05 Million Holdings in Incyte Corporation $INCY
04:00am, Saturday, 18'th Oct 2025
US Bancorp DE lifted its position in Incyte Corporation (NASDAQ: INCY) by 5.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The inst
INCY or ARGX: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 16'th Oct 2025
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and argenex SE (ARGX). But which of these two companies is the best option for those looking for
3 Biotech Stocks I Am Accumulating
02:30pm, Wednesday, 15'th Oct 2025
The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic about this area of the market. Many biotech/biopharma stocks also make good covered call tra
Incyte's (INCY) EVP and General Counsel Sold 4,100 Shares for $352,000
01:27pm, Tuesday, 14'th Oct 2025
On October 2 and October 3, 2025, Sheila A. Denton, EVP & General Counsel of Incyte (INCY 0.47%), executed an option exercise and immediately sold 4,100 shares of common stock, as disclosed in this SE
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #ESMO2025--Data from Incyte's TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the ESMO Congress 2025.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Wednesday, 08'th Oct 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Incyte to Report Third Quarter Financial Results
08:00am, Wednesday, 08'th Oct 2025
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 28, 2
Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Tuesday, 07'th Oct 2025
Incyte (INCY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:51am, Monday, 06'th Oct 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
INCY vs. ARGX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 30'th Sep 2025
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and argenex SE (ARGX). But which of these two companies is the best option for those looking for
SHENZHEN, CHINA, Sept. 28, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiaries, Dermavon Holdings Limited (“Dermavon”, an innova
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Wednesday, 24'th Sep 2025
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
